Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 8580923
Self-assembling peptide amphiphiles and related methods for growth factor delivery
granted -
US 8580944
Suppressors of CpG oligonucleotides and methods of use
granted -
US 8580748
Peptides for the treatment of hearing
granted -
US 8580735
Local complement inhibition for treatment of complement-mediated disorders
granted -
US 8580263
Anti-EGFR family antibodies, bispecific anti-EGFR family antibodies and methods of use thereof
granted -
US 8580773
Small-molecule inhibitors of the androgen receptor
granted -
US 8580738
Methods for treatment of reperfusion injury and other cardiac conditions
granted -
US 8580845
Functionalized expanded porphyrins
granted -
US 8580802
Pyrrolo[2,3-D]pyrimidines as inhibitors of Janus kinases
granted -
US 8580811
Androgen receptor modulator methods
granted -
US 8580822
Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
granted -
US 8580927
Engineered antibody constant domain molecules
granted -
US 8580844
Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities
granted -
US 8580852
2-oxamide inhibitors of phospholipase A2 activity and cellular arachidonate release based on dipeptides and pseudopeptides
granted -
US 8580768
Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes
granted -
US 8580936
Polynucleotides encoding FGFR1-IIIc ECD fusion proteins
granted -
US 8580819
Deuterated N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof
granted -
US 8580252
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
granted -
US 8580249
Cell therapy for the treatment of lysosomal storage disorders
granted -
US 8580921
Protein nanorings
granted -
US 8580231
Compositions and methods comprising magnetic resonance contrast agents
granted -
US 8580290
Heparosan-based biomaterials and coatings and methods of production and use thereof
granted -
US 8580293
Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
granted -
US 8580245
Compositions and methods for treating and preventing cardiomyopathy and heart disease
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.